AlphaYou
Overview
Smart money at a glance
Filings to Oct 7, 2026No insider open-market trades in 90 days (SEC Form 4). Congress: no trades disclosed in 180 days.
- Company insidersSEC Form 4, last 90 days
- $0No open-market trades
- CongressSTOCK Act, last 180 days
- NoneNo trades disclosed
- Big fundsSEC 13F, quarter ended Mar 31, 2026
- 1 added, 0 cutMore adding
- Federal contractsUSAspending.gov, last 12 months
- No awardsNone on record
Market overview
Fundamentals Oct 7- 52-wk high
- $48.33
- 52-wk low
- $23.14
- Mkt cap
- $2.67B
- P/E
- 40.9x
- Fwd P/E
- 30.2x
- Beta
- 0.02
- P/S
- 1.8x
- P/B
- 11.2x
- Profit margin
- +4.5%
- Op margin
- +3.5%
- ROE
- +30.4%
What do analysts expect?
Analyst target and ratings are on paid plans
See the 12-month consensus target and the buy/hold/sell rating split.
Unlock the full resultsQuestions about GRDN filings
Are insiders buying or selling Guardian Pharmacy Services, Inc. (GRDN) stock?
Neither. Guardian Pharmacy Services, Inc. (GRDN) insiders filed no open-market purchases or sales in the 90 days to Oct 7, 2026, according to SEC Form 4 filings.
Which members of Congress have traded GRDN recently?
None. No member of Congress disclosed a GRDN trade with a trade date in the last 180 days, according to House and Senate STOCK Act filings.
How current is this GRDN smart-money data?
This summary uses filings available on Oct 7, 2026. Insiders must report trades to the SEC within 2 business days, members of Congress have up to 45 days to disclose a trade, and funds file 13F holdings up to 45 days after each quarter ends, so the latest moves may not be public yet.
Smart money
What funds are doing
Buys/Adds (1)
- FM
FMR LLC
$88.8M
added
How top traders are positioned
No tracked top-trader positions in GRDN right now.
Live Hyperliquid positioning - not every stock is covered
Activist stakes, short interest & more
Earnings
Earnings landed in line with what analysts expected.
Last report
Aug 6, 2026
Period ending
Jun 30, 2026
Earnings per share
$0.24 expected
Revenue
No reported revenue on record
Previous reports
All values in USD| Period ending | Reported | EPS / estimate | EPS surprise | Revenue / estimate | Rev. surprise |
|---|---|---|---|---|---|
| Jun 30, 2026 | Aug 6, 2026 | $0.24 / $0.24Alpha Vantage | +0.00% in line | Unavailable | Unavailable |
| Mar 31, 2026 | May 6, 2026 | $0.29 / $0.24Alpha Vantage | +20.83% beat | Unavailable | Unavailable |
| Dec 31, 2025 | Mar 11, 2026 | $0.37 / $0.27Alpha Vantage | +38.32% beat | Unavailable | Unavailable |
| Sep 30, 2025 | Nov 10, 2025 | $0.25 / $0.24Alpha Vantage | +4.17% beat | Unavailable | Unavailable |
| Jun 30, 2025 | Aug 11, 2025 | $0.22 / $0.22Alpha Vantage | +0.00% in line | Unavailable | Unavailable |
| Mar 31, 2025 | May 12, 2025 | $0.21 / $0.22Alpha Vantage | -4.55% miss | Unavailable | Unavailable |
| Dec 31, 2024 | Mar 26, 2025 | $0.24 / $0.22Alpha Vantage | +8.23% beat | Unavailable | Unavailable |
| Sep 30, 2024 | Nov 12, 2024 | $0.28 / $0.19Alpha Vantage | +47.37% beat | Unavailable | Unavailable |
EPS uses Yahoo Finance where available, then Alpha Vantage or verified release comparisons. Revenue uses company releases and saved estimates.
Reports Nov 9, 2026, in 33 days
Financials
The three statements
Technicals
Price structure
Market data unavailable.
News
What the news says
Coverage leans bullish
Guardian Pharmacy Services, Inc. (GRDN) Stock Price, News, Quote & History
Leans bullishSep 29One-for-one share conversion at Guardian Pharmacy (GRDN) involves a director's holding company.
NeutralSep 29Form 4 Guardian Pharmacy Services Inc For: 28 September
NeutralSep 29Form 13D/A Guardian Pharmacy Services For: 28 September
NeutralSep 29Guardian Pharmacy executive converts 641,870 shares
NeutralSep 29Retirement meant forfeited stock awards for a Guardian Pharmacy (GRDN) insider, alongside a share conversion.
NeutralSep 29Form 4 Guardian Pharmacy Services Inc For: 28 September By Investing.com
NeutralSep 28Guardian Pharmacy converts 6.1M shares to Class A
NeutralSep 28
Macro
10 macro signals shaping GRDN right now
Unlock sector rotation, regime shifts, and macro event windows tied to this stock.
Unlock the full results